EBS

Emergent Bio
NYSE

Real-time Quotes | Nasdaq Last Sale

57.66
+0.63
+1.10%
After Hours: 57.66 0 0.00% 17:01 04/03 EDT
OPEN
56.13
PREV CLOSE
57.03
HIGH
58.77
LOW
55.90
VOLUME
363.08K
TURNOVER
--
52 WEEK HIGH
71.19
52 WEEK LOW
39.11
MARKET CAP
3.00B
P/E (TTM)
56.11
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EBS stock price target is 71.83 with a high estimate of 75.00 and a low estimate of 67.00.

EPS

EBS News

More
  • Emergent BioSolutions, Eyeing Two Plasma Therapies for Covid-19, Wins Fed's Help
  • TheStreet.com · 11h ago
  • FDA Urges COVID-19 Survivors to Donate Blood Plasma to Treat Others
  • MotleyFool.com · 2d ago
  • These D.C.-area biotech companies are making progress on COVID-19. Heres the latest.
  • American City Business Journals · 2d ago
  • FDA announces initiatives for antibody blood products for COVID-19
  • Seeking Alpha - Article · 2d ago

Industry

Pharmaceuticals
-0.14%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About EBS

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
More

Webull offers kinds of Emergent Biosolutions Inc stock information, including NYSE:EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions.